Vitamin D Supplements May Lower Blood Pressure in Seniors Who Are Overweight
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 20, 2024 -- Among older individuals who are overweight, vitamin D supplementation coadministered with calcium reduces systolic and diastolic blood pressure (SBP and DBP), according to a study published online Nov. 12 in the Journal of the Endocrine Society.
Maya Rahme, from the American University of Beirut Medical Center, and colleagues examined the effect of two doses of cholecalciferol (vitamin D3) supplementation coadministered with calcium on SBP and DBP. Ambulatory, older adults with overweight (221) received a calcium dose and oral vitamin D3 at 600 or 3,750 IU/day equivalent.
The researchers found a significant decrease in SBP and DBP in the overall group and in the high-dose group at six and 12 months. Trends were similar in the low-dose group but did not reach statistical significance. SBP decreased significantly in both treatment groups among individuals with body mass index (BMI) >30 kg/m2, while a significant decrease in DBP was only seen in the high-dose group. In the subgroups of 143 participants with hypertension, there was a decrease in SBP and DBP at six and 12 months, independent of BMI levels and at both vitamin D levels. BMI and baseline SBP significantly predicted SBP at six and 12 months, but vitamin D treatment dose did not in multivariate linear mixed models with random effects in the overall group of participants.
"Our trial and critical synthesis of data from other relevant randomized controlled trials suggest a putative beneficial effect of vitamin D in older populations with inadequate vitamin D levels and hypertension," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
GLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension
MONDAY, July 21, 2025 -- For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved...
ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension
FRIDAY, July 18, 2025 -- All individuals with hypertension should be screened for primary aldosteronism (PA), according to a clinical practice guideline issued by the Endocrine...
Delays in HTN Diagnosis Linked to Delays in Medication Prescribing
THURSDAY, July 17, 2025 -- Delays in diagnosis of hypertension are common and associated with delays in treatment initiation, according to a study published online July 14 in JAMA...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.